- Home
- LIVN vs GOF Comparison
LIVN vs GOF Comparison
Compare LIVN & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LIVN
- GOF
- Stock Information
- Founded
- LIVN 1987
- GOF 2006
- Country
- LIVN United Kingdom
- GOF United States
- Employees
- LIVN N/A
- GOF N/A
- Industry
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- GOF Finance/Investors Services
- Sector
- LIVN Health Care
- GOF Finance
- Exchange
- LIVN Nasdaq
- GOF Nasdaq
- Market Cap
- LIVN 2.1B
- GOF 2.4B
- IPO Year
- LIVN 1993
- GOF N/A
- Fundamental
- Price
- LIVN $46.08
- GOF $14.88
- Analyst Decision
- LIVN Strong Buy
- GOF
- Analyst Count
- LIVN 7
- GOF 0
- Target Price
- LIVN $59.29
- GOF N/A
- AVG Volume (30 Days)
- LIVN 593.2K
- GOF 789.2K
- Earning Date
- LIVN 07-30-2025
- GOF 01-01-0001
- Dividend Yield
- LIVN N/A
- GOF 15.42%
- EPS Growth
- LIVN N/A
- GOF N/A
- EPS
- LIVN N/A
- GOF N/A
- Revenue
- LIVN $1,275,380,000.00
- GOF N/A
- Revenue This Year
- LIVN $8.10
- GOF N/A
- Revenue Next Year
- LIVN $5.76
- GOF N/A
- P/E Ratio
- LIVN N/A
- GOF N/A
- Revenue Growth
- LIVN 7.62
- GOF N/A
- 52 Week Low
- LIVN $32.48
- GOF $10.96
- 52 Week High
- LIVN $57.35
- GOF $16.76
- Technical
- Relative Strength Index (RSI)
- LIVN 58.20
- GOF 58.54
- Support Level
- LIVN $44.28
- GOF $14.76
- Resistance Level
- LIVN $46.30
- GOF $14.95
- Average True Range (ATR)
- LIVN 1.18
- GOF 0.13
- MACD
- LIVN -0.18
- GOF 0.02
- Stochastic Oscillator
- LIVN 71.13
- GOF 85.42
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.